DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

EXACT Sciences Corp (NASDAQ: EXAS)

9.23 0.34 (3.82%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXAS $9.23 3.82%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.87
Previous Close $8.89
Daily Range $8.87 - $9.73
52-Week Range $6.79 - $32.85
Market Cap $889.2M
P/E Ratio -5.26
Dividend (Yield) $0.00 (0.0%)
Volume 1,604,048
Average Daily Volume 4,027,078
Current FY EPS -$1.76




Drug Makers

EXACT Sciences Corp (EXAS) Description

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website:

News & Commentary Rss Feed

Why KaloBios Pharmaceuticals, Eldorado Resorts, and Exact Sciences Jumped Today

These stocks posted gains on a short, quiet post-Thanksgiving trading session. Find out why.

Whitney Tilson's Robin Hood Conference Presentation

Epigenomics Down But Is It Out?

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Why Exact Sciences Shares Are Soaring 10% Today

Exact Sciences colon cancer test volume is climbing and there's still a chance that its test can get a nod on final colon cancer screening guidelines.

EXACT Sciences (EXAS) Kevin T. Conroy on Q3 2015 Results - Earnings Call Transcript

Exact (EXAS) Showing Signs Of Being Water-Logged And Getting Wetter

Today's Dead Cat Bounce Stock Is Exact (EXAS)

Exact (EXAS) In A Perilous Reversal

Dyax, Juno Therapeutics Soar Following Biotech Index Rebalance

See More EXAS News...

EXAS's Top Competitors

EXAS $9.23 (3.82%)
Current stock: EXAS
AMGN $163.52 (-0.26%)
Current stock: AMGN
GILD $108.00 (0.20%)
Current stock: GILD
BIIB $293.21 (0.31%)
Current stock: BIIB